RECRUITING

Fitness and Nutrition in Glioma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a pilot study assessing the effects of combining a modified Atkins diet with a physical fitness regimen in patients with malignant glioma. A sample size of 15 participants will be enrolled in a 15-week program consisting of two weekly supervised exercise sessions combined with an individualized home exercise program and a modified Atkins diet.

Official Title

A Pilot Study to Investigate the Effects of Combining a Modified Atkins Diet With a Physical Fitness Regimen in Patients Diagnosed With Malignant Glioma

Quick Facts

Study Start:2024-10-01
Study Completion:2026-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06665373

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Tissue confirmed diagnosis of high-grade glioma (World Health Organization grade III or IV)
  2. * Karnofsky Performance Status (KPS) ≥ 70%
  3. * Willing to follow the study intervention and follow-up
  4. * Able to give full informed consent
  1. * Currently undergoing initial concurrent radiation/chemotherapy
  2. * Severe medical co-morbidities
  3. * Any medical condition which prohibits moderate to vigorous physical activity (60-85% HRmax)
  4. * Any medical condition which prohibits a restrictive diet
  5. * Neurological deficit preventing participation in moderate to vigorous physical activity
  6. * Severe psychiatric illness

Contacts and Locations

Study Contact

Cathryn Lapierre
CONTACT
646-201-5762
Cathryn.lapierre@nyulangone.org
Lee Tessler, MD
CONTACT
516-324-7500
Lee.tessler@nyulangone.org

Principal Investigator

Lee Tessler, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Lee Tessler, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2026-10

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2026-10

Terms related to this study

Additional Relevant MeSH Terms

  • Malignant Glioma